Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
The chemokine receptor CCR5 Δ32 allele in natalizumab-treated multiple sclerosis.
Is it time for a new global classification of multiple sclerosis?
Association of NOD1 and NOD2 polymorphisms with Guillain-Barré syndrome in Northern Indian population.
Review of MR elastography applications and recent developments.
Biochemical Markers of Autoimmune Diseases of the Nervous System.
Quantitative MRI and Cerebrospinal Fluid Inflammatory Mediators in Brazilian Patients with Relapsing-Remitting Multiple Sclerosis before and after Treatment with Immunomodulators: A Longitudinal Study.
Isolated trigeminal nerve palsy with motor involvement as a presenting manifestation of multiple sclerosis in an equatorial region - a case report.
The effect of vitamin a supplementation on disease progression, cytokine levels and gene expression in multiple sclerotic patients: study protocol for a randomized controlled trial.
COMPARE: pharmacokinetic profiles of subcutaneous peginterferon beta-1a and subcutaneous interferon beta-1a over 2 weeks in healthy subjects.
Drug record: Amiloride
No association between chronic cerebrospinal venous insufficiency and pediatric-onset multiple sclerosis.
The role of growth factors as a therapeutic approach to demyelinating disease.
Minocycline reduces gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis.
Astrocytes Underlie Neuroinflammatory Memory Impairment.
Natalizumab treatment reduces L-selectin (CD62L) in CD4+ T cells.
Patients with MS under daclizumab therapy mount normal immune responses to influenza vaccination.
IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases.
Genome-wide association study of multiple sclerosis confirms a novel locus at 5p13.1.
Aquatic exercise effect on fatigue and quality of life of women with multiple sclerosis: a randomized controlled clinical trial.
Iron and Non-Iron-Related Characteristics of Multiple Sclerosis and Neuromyelitis Optica Lesions at 7T MRI.
Biplanar MRI for the assessment of the spinal cord in multiple sclerosis.
Substance Name: Dronabinol
Phenytoin protects central axons in experimental autoimmune encephalomyelitis.
Epidural blood patch in a patient with multiple sclerosis: is it safe?
Comment on the letter by Messori et al. (European Journal of Neurology 2013; 20: e131).
Pages
« first
‹ previous
…
127
128
129
130
131
132
133
134
135
…
next ›
last »